| pubmed-article:12808165 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12808165 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:12808165 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:12808165 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
| pubmed-article:12808165 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:12808165 | lifeskim:mentions | umls-concept:C0040549 | lld:lifeskim |
| pubmed-article:12808165 | lifeskim:mentions | umls-concept:C0048212 | lld:lifeskim |
| pubmed-article:12808165 | lifeskim:mentions | umls-concept:C1880989 | lld:lifeskim |
| pubmed-article:12808165 | lifeskim:mentions | umls-concept:C1880177 | lld:lifeskim |
| pubmed-article:12808165 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:12808165 | pubmed:dateCreated | 2003-6-16 | lld:pubmed |
| pubmed-article:12808165 | pubmed:abstractText | Increasing evidence indicates that lipophilic and/or protein-bound substances such as p-cresol are responsible for adverse physiological alterations in uraemic patients. To better understand the evolution of p-cresol disposition in renal failure and dialysis patients, it is necessary to determine its kinetic characteristics and biotransformation pathways. | lld:pubmed |
| pubmed-article:12808165 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12808165 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12808165 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12808165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12808165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12808165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12808165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12808165 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12808165 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12808165 | pubmed:issn | 0931-0509 | lld:pubmed |
| pubmed-article:12808165 | pubmed:author | pubmed-author:VanholderRaym... | lld:pubmed |
| pubmed-article:12808165 | pubmed:author | pubmed-author:LameireNorber... | lld:pubmed |
| pubmed-article:12808165 | pubmed:author | pubmed-author:LesafferGerri... | lld:pubmed |
| pubmed-article:12808165 | pubmed:author | pubmed-author:BelpaireFrans... | lld:pubmed |
| pubmed-article:12808165 | pubmed:author | pubmed-author:CornelisRitaR | lld:pubmed |
| pubmed-article:12808165 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:12808165 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:12808165 | pubmed:author | pubmed-author:De SmetRitaR | lld:pubmed |
| pubmed-article:12808165 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12808165 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:12808165 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12808165 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12808165 | pubmed:pagination | 1299-306 | lld:pubmed |
| pubmed-article:12808165 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:meshHeading | pubmed-meshheading:12808165... | lld:pubmed |
| pubmed-article:12808165 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12808165 | pubmed:articleTitle | Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization. | lld:pubmed |
| pubmed-article:12808165 | pubmed:affiliation | Renal Division, Heymans Institute, University Hospital, Gent, Belgium. gerrit.lesaffer@kahosl.be | lld:pubmed |
| pubmed-article:12808165 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12808165 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12808165 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12808165 | lld:pubmed |
